Klaus‐Peter Dieckmann

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi et al. · Journal of Clinical Oncology · 2019 · 343 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

Peter Albers, Roswitha Siener, S. Krege et al. · Journal of Clinical Oncology · 2008 · 340 citations

Medicine, Oncology, Surgery +14

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, Rainer Souchon, Peter Albers et al. · European Urology · 2008 · 252 citations

Medicine, Cancer Biology, Oncology +17

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours

Klaus‐Peter Dieckmann, Arlo Radtke, Meike Spiekermann et al. · European Urology · 2016 · 206 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms.

Klaus‐Peter Dieckmann, V. Loy · Journal of Clinical Oncology · 1996 · 177 citations

Medicine, Oncology, Pathology +16